
How Many Percutaneous Puncture Surgical Robots Are There in China?
As of August 25, 2026, China had 23 registration certificates related to percutaneous puncture surgical robots across 15 registrants. MedRobot examines the companies, clinical applications and product evolution behind the approvals, as well as the gap between regulatory expansion and publicly disclosed sales.
November 1, 2026

China's Surgical Robotics Industry in 2026: Why It Matters to the World
This article examines the China surgical robotics market in 2026, exploring its manufacturers, NMPA approvals, hospital procurement trends, and international expansion. Based on original industry research from MedRobot, China's surgical robotics sector recorded at least 611 systems in 2025 and 366 systems in the first half of 2026 under a methodology that includes domestic market activity and overseas sales by Chinese manufacturers. The analysis highlights the growing competitiveness of Chinese surgical robot companies, their progress in global markets, and the commercial challenges surrounding hospital adoption, equipment costs, clinical training, and reimbursement.
October 28, 2026

85 Units Awarded in Public Tenders! China Surgical Robot Market Watch, Q3 2026
MedRobot’s Q3 2026 tally captures 85 surgical robot units awarded via public hospital tenders across China, totalling around RMB 537 million. Orthopaedic robots led by unit volume, laparoscopic systems dominated contract value, while neurosurgical awards remained concentrated among two domestic vendors. The dataset covers laparoscopic, orthopaedic, neurosurgical, dental, puncture and vascular interventional robots and tracks shifting hospital adoption patterns, with important caveats that tender awards are not equivalent to installed or clinically active systems.
October 14, 2026

NHSA Launches New Plan: Medical Devices Face Three Nationally Unified Payment Gateways
China’s NHSA has launched the first national basic medical insurance catalog for medical service items, covering 13 clinical categories. Together with standardized pricing items and consumables reimbursement reform, the policy is creating a more unified payment framework for medical device market access.
September 18, 2026




